The Board of Directors of Aurobindo Pharma has
approved the acquisition of 68,97,525 equity shares of Rs.10 each of Ranit Pharma at Rs.14.50
per share amounting
to Rs.10 crores.
Ranit
Pharma is a profit making, dividend paying and an unlisted company under the same management. The acquisition of 79.37% equity in Ranit
Pharma will enhance shareholder value by bringing this company in the Aurobindo fold.
With
this acquisition, Ranit Pharma will become a subsidiary company of Aurobindo Pharma with
effect from 4th April, 2002. |
PRESS
ROOM 
